Extended-spectrum-β-lactamase-producing Enterobacteriaceae (ESBL-E) and carbapenemase-producing Enterobacteriaceae (CPE) are of global health importance, yet there is a paucity of surveillance studies on food animals in Hong Kong. Here, we report a high prevalence of ESBL-E (ranging from 0.5% to 52.4%) and CPE (0% to 9.9%) from various food animal samples procured from wet markets across Hong Kong. All CPE strains were characterized by whole-genome sequencing and possessed NDM-1 and -5 genes and other resistance determinants. Given the increased resistance profile of these strains, this study highlights the emerging threat of ESBL-E and CPE disseminated in farmed animals. Furthermore, our data enriched our understanding of antibiotic resistance reservoirs from a One Health perspective that can widely spread across various niches, beyond health care settings.
KEYWORDS: ESBL, CPE, Enterobacteriaceae, freshwater fish, pigs, livestock, One Health, aquaculture, antimicrobial resistance
ABSTRACT
This study identified and characterized extended-spectrum-β-lactamase-producing Enterobacteriaceae (ESBL-E) and carbapenemase-producing Enterobacteriaceae (CPE) from farmed freshwater fish and pig offal procured from the wet markets across Hong Kong. During March 2018 to January 2019, 730 food animal samples, namely, 213 snakehead fish, 198 black carp, and 339 pig organs, were examined. ESBL-E and CPE were isolated from the homogenized samples plated on selective media and identified by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF-MS). All ESBL-E and CPE strains were tested for antimicrobial susceptibilities. ESBL-E and CPE gene groups were detected by multiplex PCR and blaCTX-M-1/-2/-9 group strains were Sanger sequenced for CTX-M types. All CPE isolates were whole-genome sequenced. Isolation of ESBL-E from pig small (52.4%) and large (50%) intestines and tongues (25.1%) was significantly (P < 0.05) more frequent than from snakehead (0.94%) and black carp (0.5%) fish. ESBL-E isolates (n = 171) revealed resistance rates of 16.3%, 29.8%, 35.6%, 53.2%, 55.0%, and 100% to piperacillin-tazobactam, amoxicillin-clavulanate, cefepime, gentamicin, ciprofloxacin, and ampicillin, respectively, whereas CPE (n = 28) were resistant to almost all the antibiotics tested except gentamicin, ciprofloxacin, and fosfomycin. The predominant ESBL gene groups in fishes and pig offals were blaCTX, where blaCTX-M-55 was the major subtype in the blaCTX-M-1 group (64.4% of isolates in the group). blaCTX-M-14/-17 was the major genotype in the blaCTX-M-9 group (32.2%). All CPE strains possessed blaNDM genes. High rates of ESBL-E and CPE were identified in food animals from wet markets of Hong Kong, which may serve as a potential reservoir of antimicrobial-resistant genes and increase the challenges in tackling antimicrobial resistance beyond health care settings.
IMPORTANCE Extended-spectrum-β-lactamase-producing Enterobacteriaceae (ESBL-E) and carbapenemase-producing Enterobacteriaceae (CPE) are of global health importance, yet there is a paucity of surveillance studies on food animals in Hong Kong. Here, we report a high prevalence of ESBL-E (ranging from 0.5% to 52.4%) and CPE (0% to 9.9%) from various food animal samples procured from wet markets across Hong Kong. All CPE strains were characterized by whole-genome sequencing and possessed NDM-1 and -5 genes and other resistance determinants. Given the increased resistance profile of these strains, this study highlights the emerging threat of ESBL-E and CPE disseminated in farmed animals. Furthermore, our data enriched our understanding of antibiotic resistance reservoirs from a One Health perspective that can widely spread across various niches, beyond health care settings.
INTRODUCTION
Extended-spectrum-β-lactamase-producing Enterobacteriaceae (ESBL-E) and carbapenemase-producing Enterobacteriaceae (CPE) are making a significant impact on antimicrobial resistance (AMR) due to their capability of horizontal gene transfer to other bacteria (1–4). The isolation rate of ESBL-E from humans soared in the past few decades, and the emergence of CPE around the globe has been described as foreshowing the end of the antibiotic era, with an urgent threat to public health worldwide (1–6). ESBL-E and CPE in food animals and their environment have been considered potential sources of resistant bacterial infections in the community (1). Increased consumption of antimicrobials, such as β-lactams, macrolides, aminoglycosides, polymyxins, and carbapenems, is observed on animal farms (1–3, 7, 8). Misuse of antibiotics in food animals, especially those used in the treatment of human infection, may lead to dissemination of highly mobile genetic elements in pathogenic bacteria that confer resistance to antimicrobials beyond the realm of health care settings to the community (1, 7, 8).
Animal-based food production is growing rapidly in Asia, with China as the world’s biggest producer of farmed fish in 2016, claiming over 60% (49.2 million tonnes) of the world’s production (80.0 million tonnes). The country has also been providing 54.5 million tonnes of pork around the world, supporting 50% of the global demand (9, 10). A consequence of the extensive use of antibiotics in aquaculture and pig farms could be the isolation of multidrug-resistant bacteria in these farms and their produce, which can eventually interfere with human gut commensals when animal food is consumed raw or undercooked.
Apart from therapeutic purposes, antibiotics are also administered to healthy animals for growth promotion or prevention of disease to improve production yields in regions round the globe (11). As a result, drug-resistant bacteria are frequently found in surveillance programs worldwide in farm animals, which led to hypotheses of potential spread of AMR bacteria to humans via the food chain and contaminated water (11, 12). There is limited understanding of the impact of the transmission of drug-resistant bacteria from animals to humans, yet there is a rising threat of AMR to global public health that requires action from societies and government sectors (10, 11). In addition to increased AMR awareness among professionals and consumers, surveillance systems for animal antibiotic use and antimicrobial resistance improve animal husbandry and are cornerstones to promote rational antibiotic use in animals (11).
In Hong Kong, fresh food products are often purchased from traditional wet markets. Currently, there are 97 public markets which are distributed across all districts in Hong Kong. They are run by the Food and Environmental Hygiene Department of Hong Kong SAR (13). Generally, the wet markets sell fresh meat, including poultry, beef, pork, etc., supplied from three licensed slaughterhouses (14) and include animal parts such as offal, head, tail, and feet, which are ingredients of the local cuisine. Live poultry are sold only at certain markets, with interventions in place to minimize zoonotic influenza transmission (15), while live marine fish and seafood may also be kept in “aquariums” before being sold.
Our present study sought to isolate and characterize ESBL-E and CPE from freshwater fish and pig gastrointestinal tract (GIT) organs procured from wet markets across Hong Kong during the period of April 2018 to January 2019 in order to understand the prevalence and significance of antimicrobial resistance in Hong Kong.
RESULTS
Prevalence of ESBL-E and CPE in freshwater fish and pig organs.
A total of 171 ESBL-E and 28 CPE strains were isolated in our study from 411 fish and 339 pig organs that were purchased in wet markets across all 18 districts of Hong Kong. Thirty-nine of the samples contained 2 ESBL-E species and/or CPE species. The percentages of food samples with ESBL-E isolated were 52.4% (44/84) of pig’s small intestine, 50% (32/64) of large intestine, 25.1% (43/171) of pig tongue, 0.9% (2/213) of snakehead fish, and 0.5% (1/198) of black carp samples. In addition to the low isolation rates of ESBL-E in fish, no CPE were identified from freshwater fish samples. However, 28 CPE strains were isolated from pig gastrointestinal tract (GIT) organs, with a prevalence rate of 8.15% (26/319). No ESBL-E or CPE were isolated from pigs’ livers, kidneys, tails, minced meat, or snout during our preliminary examination; thus, samples from these sites were not further investigated.
The percentages of ESBL-E and CPE isolated from pig GIT organs from 3 regions, the New Territories, Kowloon, and Hong Kong Island, were compared (Fig. 1). ESBL-E and CPE were identified in 17.7% (ranging from 17.7% to 85.7%) and 4% of pig organs (ranging from 4% to 14.3%), respectively, across Hong Kong. Escherichia coli and Klebsiella pneumoniae were the major ESBL-E and CPE species in our study (Table 1). Isolation of ESBL-producing E. coli (ESBL-E. coli) was more frequent than ESBL-producing Klebsiella spp. (138 versus 33 isolates, respectively, where the latter included 29 Klebsiella pneumoniae, 3 Klebsiella variicola, and 1 Klebsiella oxytoca isolate). Four ESBL-E. coli strains were isolated from 2 snakehead fish, while 1 ESBL-producing K. pneumoniae (ESBL-K. pneumoniae) strain was isolated from 1 black carp, but no CPE were found. Twenty-eight CPE strains (25 E. coli and 3 K. pneumoniae strains) (Table 1) were isolated from 26 of 319 pig GIT organs (8.15%). Carbapenemase-producing K. pneumoniae (CP-K. pneumoniae) was isolated from 1.17% (2/171) and 1.56% (1/64) of tongues and large intestines, respectively, but none of the small intestine specimens were positive for CP-K. pneumoniae.
TABLE 1.
Source | No. (%) of strains recovered |
|||||
---|---|---|---|---|---|---|
ESBL-E |
CPE |
|||||
Total (n = 171 [100%]) | E. coli (n = 138 [80.7%]) | Klebsiella spp. (n = 33 [19.3%]) | Total (n = 28 [100%]) | E. coli (n = 25 [89.28%]) | Klebsiella pneumoniae (n = 3 [10.72%]) | |
Snakehead fish | 4 (2.35) | 4 (2.35) | ||||
Black carp | 1 (0.58) | 1 (0.58)a | ||||
Pig tongue | 55 (32.16) | 46 (26.9) | 9 (5.3)b | 17 (9.94) | 15 (53.58) | 2 (7.14) |
Pig small intestine | 56 (32.75) | 43 (25.15) | 13 (7.6)c | 5 (5.95) | 5 (17.85) | |
Pig large intestine | 55 (32.16) | 45 (26.3) | 10 (5.82) | 5 (9.38) | 6 (17.85) | 1 (3.58) |
The strain was K. pneumoniae.
Included K. pneumoniae (n = 6) and K. variicola (n = 3).
All 13 strains were K. pneumoniae.
Antibiotic susceptibility test.
All 171 ESBL-E strains and 28 CPE strains were tested for 10 and 11 antibiotics, respectively. All ESBL-E strains were 100% and 98.3% susceptible to meropenem and imipenem, respectively (3 strains showed intermediate susceptibility by disk diffusion tests according to Clinical and Laboratory Standard Institute [CLSI] guidelines). The ESBL-E strains were resistant to piperacillin-tazobactam (16.3%), amoxicillin-clavulanate (29.8%), cefepime (35.6%), gentamicin (53.2%), ciprofloxacin (54.95%), ampicillin (100%), ceftriaxone (100%), and cefotaxime (100%) (Fig. 2).
Similarly to ESBL-E, all our 28 CPE strains were resistant to piperacillin-tazobactam, ampicillin, cefepime, ceftriaxone, meropenem, imipenem, amoxicillin-clavulanate, and cefotaxime, whereas 3.5%, 10.7%, and 46.4% of the CPE strains were resistant to fosfomycin, gentamicin, and ciprofloxacin, respectively (Fig. 3).
Molecular analysis of ESBL-E and CPE strains.
ESBL gene groups were determined for our 171 ESBL-E strains (blaOXA, blaSHV, blaTEM, and blaCTX-M groups 1, 2, and 9). The most prevalent group was CTX-M (91.8% [157/171]), followed by TEM (71.9% [123/171]), SHV (16.9% [29/171]), and OXA (4.6% [8/171]). Among blaCTX-M groups, PCR results revealed that 7.65% (13/171), 36% (62/171), and 47.9% (82/171) belonged to blaCTX-M groups 1, 2, and 9, respectively. Two E. coli strains (1.1%) carried 2 blaCTX genes (blaCTX-M-1 and blaCTX-M-9 groups) and 5 E. coli strains (2.9%) carried genes from blaCTX-M-2 and blaCTX-M-9 groups. blaCTX-M-8 and blaCTX-M-25 groups were not detected among the isolates (Fig. 2). All strains positive for blaCTX-M groups 1, 2, and 9 were Sanger sequenced to delineate the possible β-lactamases as listed in Table 2. blaCTX-M-55 was the major subtype in the blaCTX-M-1 group, accounting for 64.4% (52/82) of strains, while the remaining subtypes included blaCTX-M-69, blaCTX-M-3, and blaCTX-M-226. On the other hand, blaCTX-M-14/-17 was the major subtype (32.2% [20/62]) in the blaCTX-M-9 group. Further elucidation of the subtypes of TEM, SHV, and OXA genes were not performed; thus, there is a possibility that non-ESBL TEM/SHV genes were included. However, most strains were already confirmed to be ESBL-E and to possess CTX-M genes.
TABLE 2.
Allele group | No. of positive strainsa | Enzyme(s) detected |
|
---|---|---|---|
Type | No. of strains | ||
blaCTX-G1 | 82 | CTX-M-139/-183 | 1 |
CTX-M-15b /-28/-139/-156/-163/-186/-194/-216/-224 | 2 | ||
CTX-M-15b /-28/-139/-163/-186/-194/-216/-224 | 1 | ||
CTX-M-15b /-28/-163/-186/-194/-216/-224 | 1 | ||
CTX-M-226 | 1 | ||
CTX-M-3/-22/-66/-162/-211 | 12 | ||
CTX-M-55b /-69/-79/-164/-226 | 43 | ||
CTX-M-55b /-79/-164/-226 | 9 | ||
CTX-M-69 | 12 | ||
blaCTX-G2 | 13 | NDc | |
blaCTX-G9 | 62 | CTX-M-121 | 1 |
CTX-M-122 | 1 | ||
CTX-M-130 | 4 | ||
CTX-M-14d | 2 | ||
CTX-M-14d /-17 | 20 | ||
CTX-M-17 | 5 | ||
CTX-M-24 | 8 | ||
CTX-M-24/-196 | 1 | ||
CTX-M-27/-174 | 8 | ||
CTX-M-65 | 11 | ||
CTX-M-98 | 1 |
Numbers of positive samples do not add up to a total of 171, because isolates may possess several bla genes.
CTX-M-55 and CTX-M-15 were the most predominant in the blaCTX-M-1 group.
ND, not done.
CTX-M-14 was the most predominant in the blaCTX-M-9 group.
Molecular analysis for our 28 CPE showed all the strains carried the blaNDM gene. Twenty-three of 28 CPE isolates were whole-genome sequenced, including 20 E. coli and 3 K. pneumoniae strains. Sixteen of 20 CP-E. coli carried the blaNDM-5 gene, with sequence types (ST) 410 (n = 4), ST4541 (n = 4), ST457, ST877 (2 strains for each STs), and single strains of other ST types (Fig. 4). The remaining 4 strains showed the blaNDM-1 gene and were ST101 (n = 2), ST10 (n = 1), and ST2935 (n = 1). All except two CPE strains had their blaNDM genes located on the IncX3 plasmid (plasmid size approximately 46,161 bp). Genes inferring aminoglycoside resistance (ant gene), chloramphenicol resistance (floR gene), sulfonamide resistance (sul gene), tetracycline resistance, and trimethoprim resistance (dfrA gene) were observed in more than 75% (15/20) of the strains.
The genetic characteristics of CP-K. pneumoniae are described in Table 3. One ST127 strain had the blaNDM-5 gene on an IncX3 plasmid together with blaSHV and blaTEM. The other 2 strains (serotypes K154:O2 and K152:OL102) showed blaNDM-1 genes on IncX3 plasmids as well as the presence of blaSHV. Similarly to ESBL-E. coli, genes inferring trimethoprim (dfrA gene), sulfonamide (sul gene), and aminoglycoside (aac genes) resistance were found. In addition, fluoroquinolone resistance gene oqxAB was found in all 3 K. pneumoniae strains. The presence of oqxAB was associated with low to intermediate resistance to quinoxalines, quinolones, tigecycline, nitrofurantoin, and several detergents and disinfectants (16). One of the CP-K. pneumoniae strains also contained the aac(6′)-Ib-cr gene with associated ciprofloxacin resistance in accordance with previous reports (17, 18). The KP23 strain was found to carry the fosA gene in the whole-genome analysis, which may explain the phenotypic resistance to fosfomycin.
TABLE 3.
Strain | ST | Serotype | NDM | NDM plasmid | Other AMR genesa | Virulence factorsa |
---|---|---|---|---|---|---|
KP7 | 199 | K154:O2 | NDM-1 | IncX3 | blaSHV, oqxAB, qnrS, drfA, aadA, sul, tet | |
KP14 | Not found | K152:OL102 | NDM-1 | IncX3 | blaSHV, blaTEM, oqxAB, qnrB, drfA, aadA, sul, aac(3)-IId, floR, tet | ybt, iuc, fyuA |
KP23 | 127 | K30:O2 | NDM-5 | IncX3 | blaSHV, blaTEM, oqxAB, qnrB, drfA, aadA, sul, aac(3)-IId, aac(6')-Ib-cr, aph(3')-Ia, floR, tet, fosA, mphA, aph(6)-Id, aph(3′')-Ib | ybt, irp, iuc, fyuA |
BLAST cutoff of AMR gene and virulence factor coverage, 95%; identity, 95%; depth of de novo assembly contigs, 5.
DISCUSSION
There are limited data on the surveillance of ESBL-E and CPE in aquaculture and food animals, albeit similar data have been extensively reported in health care settings (19). We thus conducted this study to investigate the distribution and characteristics of ESBL-E and CPE in our food chain. This territory-wide surveillance study not only provides an update to the burden of ESBL-E and CPE in food products from wet markets but also highlights the possible exposure of these resistant bacteria in the community.
This is the first report on ESBL-E and CPE from freshwater fish sampled in Hong Kong. The ESBL-E rate for freshwater fish was low (3/411 [0.72%]) with blaCTX gene groups being the predominant ESBL gene groups. The low isolation rate may be due to the recent restriction in the use of third-generation cephalosporins in Hong Kong aquaculture (3). Our isolation rates were much lower than from studies performed in Saudi Arabia (27.2% [110/405], blaCTX-M predominance) (6), Egypt (5.1% [14/274]), and China (1.5% [3/218]) (20, 21), and ESBL genes were less heterogeneous than in another Chinese study (blaTEM, blaSHV, blaCTX-M, and blaLEN in ESBL-E. coli) (18). The predominant ESBL gene identified from fish sampled in Saudi Arabia was blaCTX-M, which was detected in all tilapias imported from Thailand (6). BlaCTX-M was also observed in all carfu fish, 60% of milkfish, 52.3% of catfish, and 34.8% of tilapia, which were all imported from India (6). The original source of our fish is believed to be local as well as from Guangdong Province (southern part of China), while enquiries with the hawkers revealed also importation from Southeast Asia, such as Vietnam. Hence, CTX-M is still the most prevalent ESBL type among freshwater fish in Southeast Asia.
ESBL-E and CPE isolation rates were much higher in pigs than in freshwater fish in Hong Kong. Our isolation rates were higher than those reported in Thailand (36.7% of 588 pig farms) (22), Portugal (24.6% of 65 pig fecal samples; blaCTX-M-1 predominance) (23), and Cameroon (11.26% [8/71] of pigs) (24). A study in Denmark identified ESBL-producing E. coli in 79% (15/19) of pig farms with high consumption of cephalosporin compared to 20% (4/20) of the pig farms with no consumption (25). The former showed a predominance of blaCTX-M followed by blaSHV genes (25). On the other hand, our results were noticeably lower than a previous surveillance study during 2008 to 2010 from pig feces (63.6% [136/214]) in Hong Kong (26). This discrepancy might be due to the differences in sample types and processing methods. It may also be due to the recently introduced food-related initiatives under the Hong Kong Strategy and Action Plan on antimicrobial resistance (AMR) and licensing control of livestock keeping, regulating the feeding of drugs and chemicals to food animals in 2017 (2, 27). Under this regulation, seven chemicals, including two antibiotics (avoparcin, clenbuterol, chloramphenicol, dienestrol, diethylstilbestrol, hexestrol, and salbutamol) are prohibited for use in food animals. Moreover, chemicals, including 36 antibiotics, have restricted usage on animals to address the concern of proper antibiotic usage and non-exceedance of drug residue levels for food safety purposes and AMR issues in Hong Kong (2, 3, 28).
Similarly to a Turkish study on fish of the Eastern Mediterranean (29), no CPE were detected in our freshwater fish. However, scanty reports of CPE in seafood were published during 2011 to 2016, with a blaVIM-1-expressing E. coli (ST10) isolated from a Venus clam (Ruditapes philippinarum) in the Mediterranean Sea (Italy) (30) and carbapenem-resistant Enterobacteriaceae in 0.6% (8/1,328) of the seafood samples from a Canadian study, where all the samples were imported from Southeast Asian countries, specifically, Vietnam and Bangladesh (31).
This is the first study in Hong Kong to report NDM-1 and NDM-5 in pig offal from local farms. However, blaNDM-1 and blaNDM-5 were also reported in China, where the former subtype was found in E. coli from diseased pigs lung samples (0.89% [3/334]) in 2013 in Guangdong Province (32) and the latter subtype from imported pigs in Hong Kong originating from Guangdong, Henan, and Hunan provinces during 2015 and 2017, where the carbapenem-resistant Enterobacteriaceae (CRE) isolation rate was 0.7% from 856 samples (33). The CRE isolation rate was as high as 60% (18/30) in environmental samples collected from pig farms in the United States (34). The increased isolation of CRE urges an immediate and sustainable plan of action to overcome the dissemination of AMR in all sectors, including agricultural, veterinary, and public health sectors, worldwide.
There is a substantial number of overseas studies on the efficacy and cost efficiency of interventions to reduce AMR (35, 36). However, local surveillance studies are limited, and it is important to investigate the possible effect and feasibility of new measures. From surveillance of AMR, the knowledge of the associated bacteria and molecular elements are important in our aim to control the multidrug-resistant (MDR) Gram-negative pathogenic infection burden in the veterinary and public health sectors (2, 3, 10, 11). Thus, our results will be valuable as a baseline to guide interventions in reducing AMR in agriculture, farms, and the community.
In conclusion, our study is the first to demonstrate the presence of ESBL genes in fish purchased from Hong Kong wet markets. Efforts should be made worldwide to closely monitor and introduce control of antibiotic resistance in aquaculture as well as pig farms. Our results depict a major reservoir of resistance genes that extend beyond our health care environments and threaten our dwindling options of effective antibiotics in future human medicine. Further epidemiological studies and detailed analyses of the mobile genetic elements encoding these genes should also be conducted to assess the full extent of zoonotic transmission and dissemination of these AMR genes between animal and humans.
MATERIALS AND METHODS
Sample collection.
Food animal samples were purchased from 18 wet markets to include one each from a district and to represent three geographical regions (New Territories, Kowloon, and Hong Kong Island) of the city. Food animals, including gut samples of 213 snakehead fish (Channa spp.) and 198 black carp (Mylopharyngodon spp.) and 339 pig organs (171 tongues, 84 small intestines, 64 large intestines, 9 minced meat samples, 4 tails, 3 livers, 3 kidneys, and 1 snout). They were obtained between April 2018 and January 2019. Samples were transported and stored at 4°C after purchase and were processed within 24 h.
Isolation of ESBL-E and CPE.
Deep tissues, where applicable in the food sample, were dissected using sterile equipment to avoid handling and environmental contamination (37). A small piece of tissue was transferred to 3 ml of normal saline and homogenized prior to seeding 10 μl of the homogenized sample on Chromid ESBL agar (bioMérieux, France), which was then incubated at 37°C for 18 to 24 h (38). Presumptive Enterobacteriaceae colonies were selected from each plate and identified by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF-MS) (Bruker Daltonics, Inc., Germany) followed by phenotypic confirmation via double disc synergy test according to CLSI guidelines (39). All confirmed ESBL-E strains were saved at −80°C in 10% (vol/vol) glycerol-brain heart infusion (BHI) broth (Oxoid, UK) for further analysis.
CPE were isolated by transferring 2 ml of homogenized normal saline suspension (mentioned above) to sterile tubes containing 8 ml of Trypticase soy broth (TSB) (Oxoid, UK) enriched with 1 mg/liter meropenem (Oxoid, UK) prior to incubation at 37°C for 18 to 24 h. Ten microliters of incubated broth was seeded on CARBA SMART agar (bioMérieux, France) and incubated at 37°C for 18 to 24 h (38, 40). Presumptive Enterobacteriaceae colonies were selected from each plate and identified by MALDI-TOF-MS followed by phenotypic confirmation using a carbapenem inactivation method (CIM) as described previously (41). All confirmed CPE strains were saved at −80°C in 10% (vol/vol) glycerol-BHI broth (Oxoid, UK) for further analysis.
Antibiotic susceptibility testing.
Antimicrobial susceptibility testing was performed using the agar disk diffusion method according to CLSI recommendations (42). The antimicrobial disks tested were piperacillin-tazobactam (PTZ; 100/10 μg), ampicillin (AM; 10 μg), gentamicin (GM; 10 μg), ciprofloxacin (CIP; 5 μg), cefepime (CFP; 30 μg), ceftriaxone (CFT; 30 μg), meropenem (MEM; 10 μg), imipenem (IMP; 10 μg), amoxicillin-clavulanate (AMC; 20/10 μg), and cefotaxime (CTX; 30 μg) for ESBL-E and additionally fosfomycin (FOS; 200 μg) for CPE strains. Escherichia coli ATCC 25922 was used as a control (42).
Screening for ESBL-producing isolates.
The combination disk method was used to confirm ESBL-E strains. In brief, pairs of disks containing cefotaxime (30 μg) and ceftazidime (30 μg) were used with and without clavulanic acid (10 μg) on the same inoculated plate containing Muller-Hinton agar (Oxoid, UK). A positive test result was defined as a ≥5-mm increase in the zone diameter compared to that of a disk without clavulanic acid (42).
Molecular characterization of ESBL-E and CPE.
(i) DNA extraction, PCR amplification, and amplicon sequencing. Two to four bacterial colonies were emulsified in 200 μl of distilled water, heated at 95°C for 15 min, and centrifuged at 16,000 × g for 5 min (43). The supernatants were directly used as the template DNA and stored at −20°C until use. All confirmed ESBL-E strains were screened using multiplex PCRs as previously described for the detection of blaCTX-M genotype groups 1, 2, and 9, blaTEM, blaSHV, blaOXA, and genes encoding carbapenemase groups, blaKPC, blaNDM, blaOXA, and blaIMP (44, 45). All ESBL-E positive for blaCTX-M genotype groups 1, 2, and 9 were further subjected to another set of PCRs for the detection of gene encoding the CTX-M enzyme by Sanger sequencing as described previously (45).
(ii) Whole-genome sequencing of CPE. DNA of CPE strains was extracted using a Wizard Genomic DNA purification kit (Promega, USA) according to the manufacturer’s protocol, followed by library preparation via a Riptide high-throughput rapid DNA library preparation kit (iGenomx, USA) according to manufacturer’s instruction. Genomes were sequenced by NextSeq mid-output 500 obtaining paired-end reads at 150 bp (Illumina, USA). Sequence reads were demultiplexed according to the manufacturer’s instructions for the library preparation kit prior to our genome assembly pipeline, as previously described (46). Briefly, de novo assembly of the sequence reads was generated by SPAdes (3.10.1) (47), where contigs with a depth of <5 and length of <500 bp were filtered. Resistant gene profiles and plasmid replicons were acquired by blasting and read mapping to ResFinder (version 2019-02-20) and PlasmidFinder (version 2018-11-20) (48, 49). Virulence factors were identified using VFDB (50). PubMLST database was used for multilocus sequence typing (MLST) (51). A pangenome tree was constructed by Roary and visualized by ETE (52, 53). The genetic environment of the carbapenemase gene was scaffolded two ways: (i) raw reads were mapped to reference plasmid by Bowtie 2 (2.3.4.1); (ii) contigs from the de novo assembly were aligned to a reference plasmid (18). If the coverage of both methods was >80%, this reference was treated as a draft plasmid.
ACKNOWLEDGMENTS
We thank our summer students Victoria Chu, Nicole Lau, Ingrid Chan, and Rachel Lau for their assistance and participation.
This project is supported by the Food and Health Bureau, Government of Hong Kong Special Administration Region and Health and Medical Research Fund (HMRF) grant number 17160212 (to M.I.).
We declare no conflict of interest.
REFERENCES
- 1.Köck R, Daniels-Haardt I, Becker K, Mellmann A, Friedrich A, Mevius D, Schwarz S, Jurke A. 2018. Carbapenem-resistant Enterobacteriaceae in wildlife, food-producing, and companion animals: a systematic review. Clin Microbiol Infect 24:1241–1250. doi: 10.1016/j.cmi.2018.04.004. [DOI] [PubMed] [Google Scholar]
- 2.The Government of the Hong Kong Special Administration Region. Hong Kong strategy and action plan on antimicrobial resistance (2017–2022) launched. The Government of the Hong Kong Special Administration Region press release 2017. https://www.info.gov.hk/gia/general/201707/10/P2017071000364.htm. Accessed 23 April 2019.
- 3.The Government of the Hong Kong Special Administration Region. 2018. Food Safety Express (for food trade). Centre for Food Safety. The Government of the Hong Kong Special Administrative Region 2018. https://www.info.gov.hk/gia/general/201503/27/P201503270442.htm. Accessed 23 April 2019.
- 4.Singh SA, Lekshmi M, Prakasan S, Nayak BB, Kumar S. 2017. Multiple antibiotic-resistant, extended spectrum-β-lactamase (ESBL)-producing enterobacteria in fresh seafood. Microorganisms 5:E53. doi: 10.3390/microorganisms5030053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Sivaraman GK, Prasad MM, Jha AK, Visnuvinayagam S, Renuka V, Remya S, Kriplani Y, Vanik D. 2017. Prevalence of extended-spectrum β-lactamase producing Escherichia coli in seafood from the retail fishery outlets of Veraval, Gujarat, India. J Environ Biol 38:523–526. doi: 10.22438/jeb/38/4/MRN-366. [DOI] [Google Scholar]
- 6.Elhadi N. 2016. Prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in imported frozen freshwater fish in Eastern Province of Saudi Arabia. Saudi J Med Med Sci 4:19–25. doi: 10.4103/1658-631X.170883. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Morrison BJ, Rubin JE. 2015. Carbapenemase-producing bacteria in the food supply escaping detection. PLoS One 10:e0126717. doi: 10.1371/journal.pone.0126717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Abraham S, Wong HS, Turnidge J, Johnson JR, Trott DJ. 2014. Carbapenemase-producing bacteria in companion animals: a public health concern on the horizon. J Antimicrob Chemother 69:1155–1157. doi: 10.1093/jac/dkt518. [DOI] [PubMed] [Google Scholar]
- 9.USDA. 2017. China: 2017 China’s Fishery Annual. https://www.fas.usda.gov/data/china-2017-chinas-fishery-annual. Accessed 23 April 23 2019.
- 10.Food and Agriculture Organization of the United Nations. 2018. 2018. The State of the World Fisheries and Aquaculture: meeting the Sustainable Development Goals. http://www.fao.org/state-of-fisheries-aquaculture. Accessed 23 April 23 2019.
- 11.World Health Organization. 2018. Antimicrobial resistance in livestock and poor-quality veterinary medicines. Bulletin of the World Health Organization 2018. https://www.who.int/bulletin/volumes/96/9/18-209585/en/. Accessed 23 April 23 2019. [DOI] [PMC free article] [PubMed]
- 12.Amos GCA, Ploumakis S, Zhang L, Hawkey PM, Gaze WH, Wellington E. 2018. The widespread dissemination of integrons throughout bacterial communities in a riverine system. ISME J 12:681–691. doi: 10.1038/s41396-017-0030-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Food and Environmental Hygiene Department, The Government of the Hong Kong Special Administrative Region. 2019. Public markets. https://www.fehd.gov.hk/english/pleasant_environment/tidy_market/overview.html. Accessed 28 February 2020.
- 14.Centre for Food Safety, The Government of the Hong Kong Special Administrative Region. 2019. Slaughterhouses and meat inspection. https://www.cfs.gov.hk/english/import/import_smi.html. Accessed 28 February 2020.
- 15.Offeddu V, Cowling BJ, Peiris JM. 2016. Interventions in live poultry markets for the control of avian influenza: a systematic review. One Health 2:55–64. doi: 10.1016/j.onehlt.2016.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Li J, Zhang H, Ning J, Sajid A, Cheng G, Yuan Z, Hao H. 2019. The nature and epidemiology of OqxAB, a multidrug efflux pump. Antimicrob Resist Infect Control 8:44. doi: 10.1186/s13756-019-0489-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wong MH, Chan EW, Liu LZ, Chen S. 2014. PMQR genes oqxAB and aac(6′)Ib-cr accelerate the development of fluoroquinolone resistance in Salmonella typhimurium. Front Microbiol 5:521. doi: 10.3389/fmicb.2014.00521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Jiang HX, Tang D, Liu YH, Zhang XH, Zeng ZL, Xu L, Hawkey PM. 2012. Prevalence and characteristics of β-lactamase and plasmid-mediated quinolone resistance genes in Escherichia coli isolated from farmed fish in China. J Antimicrob Chemother 67:2350–2353. doi: 10.1093/jac/dks250. [DOI] [PubMed] [Google Scholar]
- 19.Wilson H, Török ME. 2018. Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae. Microb Genom 4:e000197. doi: 10.1099/mgen.0.000197. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ishida Y, Ahmed AM, Mahfouz NB, Kimura T, El-Khodery SA, Moawad AA, Shimamoto T. 2010. Molecular analysis of antimicrobial resistance in Gram-negative bacteria isolated from fish farms in Egypt. J Vet Med Sci 72:727–734. doi: 10.1292/jvms.09-0538. [DOI] [PubMed] [Google Scholar]
- 21.Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359. doi: 10.1038/nmeth.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Nuangmek A, Rojanasthien S, Chotinun S, Yamsakul P, Tadee P, Thamlikitkul V, Tansakul N, Patchanee P. 2018. Antimicrobial resistance in ESBL-producing Escherichia coli isolated from layer and pig farms in Thailand. Acta Sci Vet 46:8. doi: 10.22456/1679-9216.81823. [DOI] [Google Scholar]
- 23.Gonçalves A, Torres C, Silva N, Carneiro C, Radhouani H, Coelho C, Araújo C, Rodrigues J, Vinué L, Somalo S, Poeta P, Igrejas G. 2010. Genetic characterization of extended-spectrum beta-lactamases in Escherichia coli Isolates of pigs from a Portuguese intensive swine farm. Foodborne Pathog Dis 7:1569–1573. doi: 10.1089/fpd.2010.0598. [DOI] [PubMed] [Google Scholar]
- 24.Founou LL, Founou RC, Allam M, Ismail A, Djoko CF, Essack SY. 2018. Genome sequencing of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae isolated from pigs and abattoir workers in Cameroon. Front Microbiol 9:188. doi: 10.3389/fmicb.2018.00188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Hammerum AM, Larsen J, Andersen VD, Lester CH, Skytte TSS, Hansen F, Olsen SS, Mordhorst H, Skov RL, Aarestrup FM, Agersø Y. 2014. Characterization of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli obtained from Danish pigs, pig farmers and their families from farms with high or no consumption of third- or fourth-generation cephalosporins. J Antimicrob Chemother 69:2650–2657. doi: 10.1093/jac/dku180. [DOI] [PubMed] [Google Scholar]
- 26.Ho PL, Chow KH, Lai EL, Lo WU, Yeung MK, Chan J, Chan PY, Yuen KY. 2011. Extensive dissemination of CTX-M-producing Escherichia coli with multidrug resistance to critically important antibiotics among food animals in Hong Kong, 2008–10. J Antimicrob Chemother 66:765–768. doi: 10.1093/jac/dkq539. [DOI] [PubMed] [Google Scholar]
- 27.Agriculture, Fisheries and Conservation Department. 2018. Agriculture and fisheries. https://www.afcd.gov.hk/english/quarantine/qua_live/qua_live_amr/introAMR.html. Accessed 5 April 2020.
- 28.Laws Compilation and Publication Unit. 2006. Cap 139N. Public health (animals and birds) (chemical residues) regulation. Department of Justice, Hong Kong. [Google Scholar]
- 29.Matya F. 2016. Isolation, identification and antibacterial agents resistance among Enterobacteriaceae spp. in fish of the Eastern Mediterranean. The 2016 WEI International Academic Conference proceedings, Barcelona, Spain. [Google Scholar]
- 30.Roschanski N, Guenther S, Vu TTT, Fischer J, Semmler T, Huehn S, Alter T, Roesler U. 2017. VIM-1 carbapenemase-producing Escherichia coli isolated from retail seafood, Germany 2016. Euro Surveill 22:17-00032. doi: 10.2807/1560-7917.ES.2017.22.43.17-00032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Janecko N, Martz SL, Avery BP, Daignault D, Desruisseau A, Boyd D, Irwin RJ, Mulvey MR, Reid-Smith RJ. 2016. Carbapenem-resistant Enterobacter spp. in retail seafood imported from Southeast Asia to Canada. Emerg Infect Dis 22:1675–1677. doi: 10.3201/eid2209.160305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Zhang R, Wang Y, Liu Z, Li J, Yin W, Lei L, Wu C, Shen J. 2015. Characterization of NDM-1-producing carbapenemase in Acinetobacter spp. and E. coli isolates from diseased pigs. Front Agr Sci Eng 2:223–229. doi: 10.15302/J-FASE-2015065. [DOI] [Google Scholar]
- 33.Ho PL, Wang Y, Liu MCJ, Lai ELY, Law PYT, Cao H, Chow KH. 2018. IncX3 epidemic plasmid carrying blaNDM-5 in Escherichia coli from swine in multiple geographic areas in China. Antimicrob Agents Chemother 62:e02295-17. doi: 10.1128/AAC.02295-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Mollenkopf DF, Stull JW, Mathys DA, Bowman AS, Feicht SM, Grooters SV, Daniels JB, Wittum TE. 2016. Carbapenemase-producing Enterobacteriaceae recovered from the environment of a swine farrow-to-finish operation in the United States. Antimicrob Agents Chemother 61:e01298-16. doi: 10.1128/AAC.01298-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Wilton P, Smith R, Coast J, Millar M. 2002. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and cost-effectiveness. J Health Serv Res Policy 7:111–117. doi: 10.1258/1355819021927764. [DOI] [PubMed] [Google Scholar]
- 36.Smith R, Coast J, Millar MR, Wilton P, Karcher AM. 2001. In Knobler SL, Lemon SM, Najafi M (ed), Interventions against antimicrobial resistance: a review of the literature and exploration of modelling cost-effectiveness. National Academies Press, Washington, DC. [Google Scholar]
- 37.Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, Hawkey P, Heck M, Savelkoul P, Vandenbroucke-Grauls C, Zwaluw KVD, Huijsdens X, Kluytmans J. 2011. Extended-spectrum b-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg Infect Dis 17:1216–1222. doi: 10.3201/eid1707.110209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Wilkinson KM, Winstanley TG, Lanyon C, Cummings SP, Raza MW, Perry JD. 2012. Comparison of four chromogenic culture media for carbapenemase-producing Enterobacteriaceae. J Clin Microbiol 50:3102–3104. doi: 10.1128/JCM.01613-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Clinical and laboratory Standards institute. 2007. Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA. [Google Scholar]
- 40.CDC. 2017. Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE)–November 2015 Update CRE Toolkit. https://www.cdc.gov/hai/organisms/cre/cre-toolkit/index.html. Accessed 23 April 2019.
- 41.Zwaluw KVD, Haan AD, Pluister GN, Bootsma HJ, Neeling AJD, Schouls LM. 2015. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in Gram-negative rods. PLoS One 10:e0123690. doi: 10.1371/journal.pone.0123690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Clinical and Laboratory Standards Institute. 2019. Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute, Wayne, PA. [Google Scholar]
- 43.Dashti AA, Jadaon MM, Abdulsamad AM, Dashti H. 2009. Heat treatment of bacteria: a simple method of DNA extraction for molecular techniques. J Kuwait Med Assoc 41:117–122. [Google Scholar]
- 44.Mataseje LF, Bryce E, Roscoe D, Boyd DA, Embree J, Gravel D, Katz K, Kibsey P, Kuhn M, Mounchili A, Simor A, Taylor G, Thomas E, Turgeon N, Mulvey MR, Canadian Nosocomial Infection Surveillance Program. 2012. Carbapenem-resistant Gram-negative bacilli in Canada 2009–10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J Antimicrob Chemother 67:1359–1367. doi: 10.1093/jac/dks046. [DOI] [PubMed] [Google Scholar]
- 45.Strauß LM, Dahms C, Becker K, Kramer A, Kaase M, Mellmann A. 2015. Development and evaluation of a novel universal β-lactamase gene subtyping assay for blaSHV, blaTEM and blaCTX-M using clinical and livestock-associated Escherichia coli. J Antimicrob Chemother 70:710–715. doi: 10.1093/jac/dku450. [DOI] [PubMed] [Google Scholar]
- 46.Zhu C, Liyanapathirana V, Li C, Pinto V, Hui M, Lo N, Wong KT, Dissanayake N, Ip M. 2018. Characterizing mobilized virulence factors and multidrug resistance genes in carbapenemase-producing Klebsiella pneumoniae in a Sri Lankan Hospital. Front Microbiol 9:2044. doi: 10.3389/fmicb.2018.02044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. doi: 10.1089/cmb.2012.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Carattoli A, Zankari E, García-Fernández A, Larsen MV, Lund O, Villa L, Aarestrup FM, Hasman H. 2014. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother 58:3895–3903. doi: 10.1128/AAC.02412-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. doi: 10.1093/jac/dks261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Liu B, Zheng D, Jin Q, Chen L, Yang J2. 2019. VFDB 2019: a comparative pathogenomic platform with an interactive web interface. Nucleic Acids Res 47:D687–D692. doi: 10.1093/nar/gky1080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Jolley KA, Maiden MC. 2010. BIGSdb: scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11:595. doi: 10.1186/1471-2105-11-595. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Huerta-Cepas J, Serra F, Bork P. 2016. ETE 3: reconstruction, analysis, and visualization of phylogenomic data. Mol Biol Evol 33:1635–1638. doi: 10.1093/molbev/msw046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, Fookes M, Falush D, Keane JA, Parkhill J. 2015. Rotary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 31:3691–3693. doi: 10.1093/bioinformatics/btv421. [DOI] [PMC free article] [PubMed] [Google Scholar]